Immunotherapy Treatments Approved for Small Cell Lung Cancer

The following immunotherapy is approved as first treatment:

APPROVED THERAPY:

  • Atezolizumab (Tecentriq, a PD-L1 inhibitor) in combination with chemotherapy

The following immunotherapies are approved as a 3rd treatment (after two other treatments are no longer working):

APPROVED THERAPY:

  • Opdivo (nivolumab, a PD-1 inhibitor)
  • Keytruda (pembrolizumab, a PD-1 inhibitor)

Click here for answers to frequently asked questions about immunotherapy for lung cancer.